ATTENADE DIN 02247793
Status: Cancelled Pre Market
Holder: BIOVAIL PHARMACEUTICALS CANADA DIVISION OF BIOVAIL CORPORATION
Molecule: DEXMETHYLPHENIDATE HYDROCHLORIDE
Health Canada record
| Active ingredient(s) | DEXMETHYLPHENIDATE HYDROCHLORIDE 10 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | CONTROLLED DRUGS (CDSA III) |
| Class | Human |
| ATC | N06BA11 DEXMETHYLPHENIDATE |
| Original market date | |
| Current status date | 30-Mar-2015 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DEXMETHYLPHENIDATE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02247791 | ATTENADE | BIOVAIL PHARMACEUTICALS CANADA DIVISION OF BIOVAIL CORPORATION | Tablet | DEXMETHYLPHENIDATE HYDROCHLORIDE 2.5 MG | Cancelled Pre Market |
| 02247792 | ATTENADE | BIOVAIL PHARMACEUTICALS CANADA DIVISION OF BIOVAIL CORPORATION | Tablet | DEXMETHYLPHENIDATE HYDROCHLORIDE 5 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 473 | 2003-08-11 | New Drug Submission (NDS) |
International API supply for DEXMETHYLPHENIDATE HYDROCHLORIDE
6 active FDA Drug Master Files.
Request a quote for ATTENADE